Andrea del Campo

Dr. Andrea del Campo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2013 in Diabetes
Verified
Journal Article
Open access
VPValentina Parra
Valentina Parra
HVHugo E. Verdejo
Hugo E. Verdejo
MIMyriam Iglewski
Myriam Iglewski
ACAndrea del Campo
Andrea del Campo
RTRodrigo Troncoso
Rodrigo Troncoso
SLSergio Lavandero
Sergio Lavandero
Insulin regulates heart metabolism through the regulation of insulin-stimulated glucose uptake. Studies have indicated that insulin can also regulate mitochondrial function. Relevant to this idea, mitochondrial function is impaired in diabetic individuals. Furthermore, the expression of Opa-1 and mitofusins, proteins of the mitochondrial fusion machinery, is dramatically altered in obese and insulin-resistant patients. Given the role of insulin in the control of cardiac energetics, the goal of this study was to investigate whether insulin affects mitochondrial dynamics in cardiomyocytes. Confocal microscopy and the mitochondrial dye MitoTracker Green were used to obtain three-dimensional images of the mitochondrial network in cardiomyocytes and L6 skeletal muscle cells in culture. Three hours of insulin treatment increased Opa-1 protein levels, promoted mitochondrial fusion, increased mitochondrial membrane potential, and elevated both intracellular ATP levels and oxygen consumption in cardiomyocytes in vitro and in vivo. Consequently, the silencing of Opa-1 or Mfn2 prevented all the metabolic effects triggered by insulin. We also provide evidence indicating that insulin increases mitochondrial function in cardiomyocytes through the Akt-mTOR-NFκB signaling pathway. These data demonstrate for the first time in our knowledge that insulin acutely regulates mitochondrial metabolism in cardiomyocytes through a mechanism that depends on increased mitochondrial fusion, Opa-1, and the Akt-mTOR-NFκB pathway.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
CPChristian Pennanen
Christian Pennanen
VPValentina Parra
Valentina Parra
CLCamila López-Crisosto
Camila López-Crisosto
PMPablo E. Morales
Pablo E. Morales
ACAndrea del Campo
Andrea del Campo
SLSergio Lavandero
Sergio Lavandero
Cardiomyocyte hypertrophy has been associated with diminished mitochondrial metabolism. Mitochondria are crucial organelles for the production of ATP, and their morphology and function are regulated by the dynamic processes of fusion and fission. The relationship between mitochondrial dynamics and cardiomyocyte hypertrophy is still poorly understood. Here, we show that treatment of cultured neonatal rat cardiomyocytes with the hypertrophic agonist norepinephrine promotes mitochondrial fission (characterized by a decrease in mitochondrial mean volume and an increase in the relative number of mitochondria per cell) and a decrease in mitochondrial function. We demonstrate that norepinephrine acts through α1-adrenergic receptors to increase cytoplasmic Ca2+, activating calcineurin and promoting migration of the fission protein Drp1 (encoded by Dnml1) to mitochondria. Dominant-negative Drp1 (K38A) not only prevented mitochondrial fission, it also blocked hypertrophic growth of cardiomyocytes in response to norepinephrine. Remarkably, an antisense adenovirus against the fusion protein Mfn2 (AsMfn2) was sufficient to increase mitochondrial fission and stimulate a hypertrophic response without agonist treatment. Collectively, these results demonstrate the importance of mitochondrial dynamics in the development of cardiomyocyte hypertrophy and metabolic remodeling.

1 December 2011 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
RTRodrigo Troncoso
Rodrigo Troncoso
JVJose Miguel Vicencio
Jose Miguel Vicencio
VPValentina Parra
Valentina Parra
ANAndriy Nemchenko
Andriy Nemchenko
YKYuki Kawashima
Yuki Kawashima
SLSergio Lavandero
Sergio Lavandero
Insulin-like growth factor 1 (IGF-1) is known to exert cardioprotective actions. However, it remains unknown if autophagy, a major adaptive response to nutritional stress, contributes to IGF-1-mediated cardioprotection. We subjected cultured neonatal rat cardiomyocytes, as well as live mice, to nutritional stress and assessed cell death and autophagic rates. Nutritional stress induced by serum/glucose deprivation strongly induced autophagy and cell death, and both responses were inhibited by IGF-1. The Akt/mammalian target of rapamycin (mTOR) pathway mediated the effects of IGF-1 upon autophagy. Importantly, starvation also decreased intracellular ATP levels and oxygen consumption leading to AMP-activated protein kinase (AMPK) activation; IGF-1 increased mitochondrial Ca2+ uptake and mitochondrial respiration in nutrient-starved cells. IGF-1 also rescued ATP levels, reduced AMPK phosphorylation and increased p70S6K phosphorylation, which indicates that in addition to Akt/mTOR, IGF-1 inhibits autophagy by the AMPK/mTOR axis. In mice harbouring a liver-specific igf1 deletion, which dramatically reduces IGF-1 plasma levels, AMPK activity and autophagy were increased, and significant heart weight loss was observed in comparison with wild-type starved animals, revealing the importance of IGF-1 in maintaining cardiac adaptability to nutritional insults in vivo. Our data support the cardioprotective actions of IGF-1, which, by rescuing the mitochondrial metabolism and the energetic state of cells, reduces cell death and controls the potentially harmful autophagic response to nutritional challenges. IGF-1, therefore, may prove beneficial to mitigate damage induced by excessive nutrient-related stress, including ischaemic disease in multiple tissues.

4 January 2018 in Aging
Verified
Journal Article
Open access
ACAndrea del Campo
Andrea del Campo
ICIgnacio Contreras-Hernández
Ignacio Contreras-Hernández
Mauricio Castro-SepulvedaMauricio Castro-Sepulveda
Mauricio Castro-Sepulveda
CCCristian A. Campos
Cristian A. Campos
RFReinaldo Figueroa
Reinaldo Figueroa
Enrique JaimovichEnrique Jaimovich
Enrique Jaimovich
Sarcopenia is the degenerative loss of muscle mass and strength with aging. Although a role of mitochondrial metabolism in muscle function and in the development of many diseases has been described, the role of mitochondrial topology and dynamics in the process of muscle aging is not fully understood. This work shows a time line of changes in both mitochondrial distribution and skeletal muscle function during mice lifespan. We isolated muscle fibers from flexor digitorum brevis of mice of different ages. A fusion-like phenotype of mitochondria, together with a change in orientation perpendicular to the fiber axis was evident in the Adult group compared to Juvenile and Older groups. Moreover, an increase in the contact area between sarcoplasmic reticulum and mitochondria was evident in the same group. Together with the morphological changes, mitochondrial Ca2+ resting levels were reduced at age 10-14 months and significantly increased in the Older group. This was consistent with a reduced number of mitochondria-to-jSR pairs in the Older group compared to the Juvenile. Our results support the idea of several age-dependent changes in mitochondria that are accentuated in midlife prior to a complete sarcopenic phenotype.

22 January 2011 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
VPValentina Parra
Valentina Parra
HVHugo Verdejo
Hugo Verdejo
ACAndrea del Campo
Andrea del Campo
CPChristian Pennanen
Christian Pennanen
JKJovan Kuzmicic
Jovan Kuzmicic
SLSergio Lavandero
Sergio Lavandero

1 October 2011 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JKJovan Kuzmicic
Jovan Kuzmicic
ACAndrea del Campo
Andrea del Campo
CLCamila López-Crisosto
Camila López-Crisosto
PMPablo E. Morales
Pablo E. Morales
CPChristian Pennanen
Christian Pennanen
SLSergio Lavandero
Sergio Lavandero